Ongoing blood loss and iron-deficiency anemia are common problems in patients on
hemodialysis; therefore, nephrology clinicians are particularly concerned with their patients …

Preoperative treatment of anemia with intravenous iron is inconsistent despite known risks of
anemia and allogeneic blood transfusions. Limited research exists on the effectiveness of …

The importance of iron in the manufacture of erythrocytes is self-evident. In recent years, the
treatment of anaemia of end-stage renal disease with recombinant human erythropoietin …

Iron deficiency is a frequent complication in patients with chronic kidney disease (CKD).
Major causes are reduced dietary intake, impaired absorption, chronic blood loss …

During the past two decades, routine use of recombinant erythropoeisis-stimulating agents
(ESA) has enabled anemia to be corrected in most patients with end-stage renal disease …

Iron-deficiency anemia is commonly encountered in patients with end-stage renal disease
(ESRD) requiring chronic hemodialysis and can occur as a result of blood loss from frequent …

Iron overload is a common complication in patients with chronic renal failure treated with
dialysis prior to the availability of recombinant human erythropoietin therapy. Iron overload …

The majority of patients with chronic kidney disease are anaemic. Iron deficiency should be
corrected before treatment with recombinant human erythropoietin (rhuEpo) or novel …

Background. The effect of maintenance intravenous (IV) iron administration on subsequent
achievement of anemia management goals and mortality among patients recently initiating …

In patients on chronic hemodialysis, there is no standard protocol for maintenance iron
supplementation. This study aimed to compare two fixed-dose intravenous (IV) iron …